SciVision Biotech Inc. (TPE:1786)
40.35
-1.35 (-3.24%)
Nov 20, 2026, 1:30 PM CST
SciVision Biotech Revenue
SciVision Biotech had revenue of 202.67M TWD in the quarter ending September 30, 2026, a decrease of -8.46%. This brings the company's total for the last twelve months to 870.41M, down -2.25% year-over-year. In the year 2025, SciVision Biotech had annual revenue of 886.62M with 0.37% growth. That makes SciVision Biotech the 32,216th largest company in the world by revenue and 1,662nd in Taiwan.
Revenue (ttm)
870.41M
Revenue Growth
-2.25%
P/S Ratio
3.47
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.02B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SciVision Biotech breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 886.62M | 3.31M | 0.37% |
| Dec 31, 2024 | 883.31M | 170.32M | 23.89% |
| Dec 31, 2023 | 712.99M | 155.64M | 27.93% |
| Dec 31, 2022 | 557.35M | 51.81M | 10.25% |
| Dec 31, 2021 | 505.54M | 38.66M | 8.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.40B |
| Formosa Optical Technology | 4.46B |
| St.Shine Optical | 3.63B |
| Pacific Hospital Supply | 2.43B |
| Nang Kuang Pharmaceutical | 2.09B |
| Bionime | 1.73B |
| Chi Sheng Pharma & Biotech | 1.43B |
| ICARES Medicus | 1.31B |